Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

GABAA receptors: subtypes, regional distribution, and function.

David Nutt1

  • 1Psychopharmacology Unit, University ofBristol School of Medicine Sciences, Bristol, United Kingdom.

Journal of Clinical Sleep Medicine : JCSM : Official Publication of the American Academy of Sleep Medicine
|June 15, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The goal of specificity in psychotropic drug development: A lesson from Sisyphus?

Journal of psychopharmacology (Oxford, England)·2026
Same author

Detecting neuroplastic effects induced by ketamine in healthy human subjects: A multimodal approach.

Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism·2026
Same author

Evaluation of the impact of low activity imaging in [<sup>11</sup>C]-(+)-PHNO and [<sup>11</sup>C]UCB-J PET-MR scans.

EJNMMI physics·2026
Same author

Medicines for Anxiety: A Hundred Years of Tranquillity and More to Come?

Human psychopharmacology·2026
Same author

A short-acting psychedelic intervention for major depressive disorder: a phase IIa randomized placebo-controlled trial.

Nature medicine·2026
Same author

Drug harms in Canada: A multi-criteria decision analysis.

Journal of psychopharmacology (Oxford, England)·2026

Agents modulating gamma-aminobutyric acid type A (GABAA) receptors are effective treatments for various conditions. New research into GABAA receptor subtypes and modulation offers potential for developing more selective and sophisticated drug interventions.

Area of Science:

  • Neuroscience
  • Pharmacology
  • Molecular Biology

Background:

  • Gamma-aminobutyric acid type A (GABAA) receptor modulators have been mainstays in treating anxiety, epilepsy, and sleep disorders for over four decades.
  • These drugs are recognized for their general safety, tolerability, and efficacy.

Purpose of the Study:

  • To explore the evolving understanding of GABAA receptor modulation mechanisms.
  • To highlight the potential for developing novel therapeutics targeting specific GABAA receptor subtypes.

Main Methods:

  • Review of current literature on GABAA receptor pharmacology.
  • Characterization of various GABAA receptor subtypes and their distinct functional roles.
  • Utilizing advances in genetic engineering and transgenic mouse models.

Related Experiment Videos

Main Results:

  • Significant growth in understanding the diverse mechanisms of action at different GABAA receptor sites.
  • Identification of distinct functional roles for various GABAA receptor subtypes.
  • Refined understanding of GABAA receptor subunit pharmacology and physiology through advanced models.

Conclusions:

  • The evolving knowledge of GABAA receptor modulation presents promising avenues for future drug development.
  • Targeting specific GABAA receptor subtypes could lead to more selective and sophisticated therapeutic interventions.
  • Transgenic mouse models have significantly advanced the study of GABAA receptor pharmacology and physiology.